Cargando…

Comparative Study on the Efficacy of Two Perioperative Chemotherapy Regimens for Lumbar Brucellosis

OBJECTIVE: The clinical efficacy of perioperative chemotherapy regimen (rifampicin, doxycycline, levofloxacin, ceftriaxone) was evaluated for lumbar brucellosis spondylitis patients with neurological injury. METHODS: In Beijing Ditan Hospital affiliated with Capital Medical University, 32 patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jie, Deng, Lei, Ding, Zihao, Zhang, Yaosheng, Zhang, Yao, Li, Kangpeng, Zhao, Changsong, Zhang, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691375/
https://www.ncbi.nlm.nih.gov/pubmed/38046280
http://dx.doi.org/10.2147/DDDT.S427477
_version_ 1785152726307438592
author Wang, Jie
Deng, Lei
Ding, Zihao
Zhang, Yaosheng
Zhang, Yao
Li, Kangpeng
Zhao, Changsong
Zhang, Qiang
author_facet Wang, Jie
Deng, Lei
Ding, Zihao
Zhang, Yaosheng
Zhang, Yao
Li, Kangpeng
Zhao, Changsong
Zhang, Qiang
author_sort Wang, Jie
collection PubMed
description OBJECTIVE: The clinical efficacy of perioperative chemotherapy regimen (rifampicin, doxycycline, levofloxacin, ceftriaxone) was evaluated for lumbar brucellosis spondylitis patients with neurological injury. METHODS: In Beijing Ditan Hospital affiliated with Capital Medical University, 32 patients with lumbar brucellosis spondylitis underwent surgery and triple perioperative chemotherapy (rifampicin, doxycycline, levofloxacin) between 2011 and 2021 due to neurological injury, and 34 patients matched up with the triple group underwent rifampicin, doxycycline, levofloxacin, and ceftriaxone. Both groups were compared in terms of changes in inflammation index, low back/leg pain, lumbar function, neurological function, and adverse drug reactions. RESULTS: There was no significant difference in erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), low back pain visual analogue scale (VAS), leg pain VAS, lumbar Oswestry disability index (ODI) and nerve function injury rate between the two groups before chemotherapy (P>0.05). The ESR, CRP at 1 week and 2 weeks after chemotherapy and 1 week, 2 weeks, 1 month postoperatively in the quadruple group were significantly lower than those in the triple group, which is the same to ESR 3 months postoperatively (P<0.05). The low back pain VAS, leg pain VAS and lumbar ODI in the quadruple group were significantly lower than those in the triple group at 1 month and 3 months postoperatively (P<0.05). The recovery rate of neurological function in the quadruple group was significantly higher than that in the triple group at 3 and 6 months postoperatively (P<0.05). Both groups did not experience significantly different perioperative and postoperative adverse reactions (P>0.05). CONCLUSION: For lumbar brucellosis spondylitis with neurological injury, quadruple perioperative chemotherapy of rifampicin, doxycycline, levofloxacin and ceftriaxone can significantly reduce perioperative inflammation, and improve low back/leg pain, as well as promoting neurological function recovery in the short term.
format Online
Article
Text
id pubmed-10691375
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-106913752023-12-02 Comparative Study on the Efficacy of Two Perioperative Chemotherapy Regimens for Lumbar Brucellosis Wang, Jie Deng, Lei Ding, Zihao Zhang, Yaosheng Zhang, Yao Li, Kangpeng Zhao, Changsong Zhang, Qiang Drug Des Devel Ther Original Research OBJECTIVE: The clinical efficacy of perioperative chemotherapy regimen (rifampicin, doxycycline, levofloxacin, ceftriaxone) was evaluated for lumbar brucellosis spondylitis patients with neurological injury. METHODS: In Beijing Ditan Hospital affiliated with Capital Medical University, 32 patients with lumbar brucellosis spondylitis underwent surgery and triple perioperative chemotherapy (rifampicin, doxycycline, levofloxacin) between 2011 and 2021 due to neurological injury, and 34 patients matched up with the triple group underwent rifampicin, doxycycline, levofloxacin, and ceftriaxone. Both groups were compared in terms of changes in inflammation index, low back/leg pain, lumbar function, neurological function, and adverse drug reactions. RESULTS: There was no significant difference in erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), low back pain visual analogue scale (VAS), leg pain VAS, lumbar Oswestry disability index (ODI) and nerve function injury rate between the two groups before chemotherapy (P>0.05). The ESR, CRP at 1 week and 2 weeks after chemotherapy and 1 week, 2 weeks, 1 month postoperatively in the quadruple group were significantly lower than those in the triple group, which is the same to ESR 3 months postoperatively (P<0.05). The low back pain VAS, leg pain VAS and lumbar ODI in the quadruple group were significantly lower than those in the triple group at 1 month and 3 months postoperatively (P<0.05). The recovery rate of neurological function in the quadruple group was significantly higher than that in the triple group at 3 and 6 months postoperatively (P<0.05). Both groups did not experience significantly different perioperative and postoperative adverse reactions (P>0.05). CONCLUSION: For lumbar brucellosis spondylitis with neurological injury, quadruple perioperative chemotherapy of rifampicin, doxycycline, levofloxacin and ceftriaxone can significantly reduce perioperative inflammation, and improve low back/leg pain, as well as promoting neurological function recovery in the short term. Dove 2023-11-27 /pmc/articles/PMC10691375/ /pubmed/38046280 http://dx.doi.org/10.2147/DDDT.S427477 Text en © 2023 Wang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Wang, Jie
Deng, Lei
Ding, Zihao
Zhang, Yaosheng
Zhang, Yao
Li, Kangpeng
Zhao, Changsong
Zhang, Qiang
Comparative Study on the Efficacy of Two Perioperative Chemotherapy Regimens for Lumbar Brucellosis
title Comparative Study on the Efficacy of Two Perioperative Chemotherapy Regimens for Lumbar Brucellosis
title_full Comparative Study on the Efficacy of Two Perioperative Chemotherapy Regimens for Lumbar Brucellosis
title_fullStr Comparative Study on the Efficacy of Two Perioperative Chemotherapy Regimens for Lumbar Brucellosis
title_full_unstemmed Comparative Study on the Efficacy of Two Perioperative Chemotherapy Regimens for Lumbar Brucellosis
title_short Comparative Study on the Efficacy of Two Perioperative Chemotherapy Regimens for Lumbar Brucellosis
title_sort comparative study on the efficacy of two perioperative chemotherapy regimens for lumbar brucellosis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691375/
https://www.ncbi.nlm.nih.gov/pubmed/38046280
http://dx.doi.org/10.2147/DDDT.S427477
work_keys_str_mv AT wangjie comparativestudyontheefficacyoftwoperioperativechemotherapyregimensforlumbarbrucellosis
AT denglei comparativestudyontheefficacyoftwoperioperativechemotherapyregimensforlumbarbrucellosis
AT dingzihao comparativestudyontheefficacyoftwoperioperativechemotherapyregimensforlumbarbrucellosis
AT zhangyaosheng comparativestudyontheefficacyoftwoperioperativechemotherapyregimensforlumbarbrucellosis
AT zhangyao comparativestudyontheefficacyoftwoperioperativechemotherapyregimensforlumbarbrucellosis
AT likangpeng comparativestudyontheefficacyoftwoperioperativechemotherapyregimensforlumbarbrucellosis
AT zhaochangsong comparativestudyontheefficacyoftwoperioperativechemotherapyregimensforlumbarbrucellosis
AT zhangqiang comparativestudyontheefficacyoftwoperioperativechemotherapyregimensforlumbarbrucellosis